Natalie M Czuczman

Statistics

Publications

Citations

H-Index

Active since

2013

Affiliations

Roswell Park Comprehensive Cancer Center(Current)

Natalie M Czuczman is an author at Roswell Park Comprehensive Cancer Center specializing in pharmacology, rituximab-based therapy, and molecular oncology.

Publications per year

2013–2015

Publications

The novel proteasome inhibitor carfilzomib induces cell cycle arrest, apoptosis and potentiates the anti‐tumour activity of chemotherapy in rituximab‐resistant lymphoma

Juan Gu, Francisco J. Hernandez‐Ilizaliturri, Gregory P. Kaufman et al. · British Journal of Haematology · 2013 · 42 citations · Full text

Medicine, Oncology, Pharmacology +16

Pevonedistat, a NEDD8-activating enzyme inhibitor, is active in mantle cell lymphoma and enhances rituximab activity in vivo

Natalie M Czuczman, Matthew J. Barth, Juan Gu et al. · Blood · 2015 · 36 citations · Full text

Medicine, Oncology, Pharmacology +8

MLN2238, a proteasome inhibitor, induces caspase-dependent cell death, cell cycle arrest, and potentiates the cytotoxic activity of chemotherapy agents in rituximab-chemotherapy-sensitive or rituximab-chemotherapy-resistant B-cell lymphoma preclinical models

Juan J. Gu, Francisco J. Hernandez‐Ilizaliturri, Cory Mavis et al. · Anti-Cancer Drugs · 2013 · 10 citations

Medicine, Oncology, Pharmacology +17

1–3 of 3